By: Heather Biele, Mark D Eisner, Kate Burba
SAN DIEGO — Treatment with combination tobevibart and elebsiran led to hepatitis B surface antigen loss among 39% of patients with chronic HBV and
Heather Biele is a journalist who writes for Healio, focusing on a wide range of healthcare topics. Her articles cover subjects such as organ transplantation, COVID-19, pregnancy, eye care, and various medical procedures. Heather aims to provide informative and insightful content to keep readers informed about the latest developments in healthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Heather's coverage is heavily data-centric, often citing research and medical findings. She appears to be interested in a wide range of healthcare and scientific topics, including medical research, health conditions, treatment options, public health, and patient care.
Given her focus on citing data extensively in her articles and the diverse nature of the topics she covers within healthcare and scientific fields, Heather would likely respond positively to pitches that offer access to new or significant studies with clear implications for patient care or public health.
It seems that Heather doesn't have a specific geographic focus but rather focuses on global trends in healthcare and scientific research. Therefore, sources with insights into international studies or those at the forefront of groundbreaking medical discoveries may pique her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .